The CALLY index in cancer research: a comprehensive review.

IF 4 Q2 ONCOLOGY

Oncology Reviews Pub Date : 2026-02-19 eCollection Date: 2026-01-01 DOI:10.3389/or.2026.1737805

Yangzheng Zhang, Weidong Liu

引用次数: 0

Abstract

This review focuses on the CALLY index in cancer, exploring its theoretical foundations, epidemiological insights, diagnostic and prognostic applications, therapeutic implications, controversies, and future perspectives. The CALLY index, based on C - reactive protein, albumin, and lymphocyte levels, has shown potential in predicting cancer prognosis and guiding treatment. Multiple studies across various cancer types indicate its association with survival outcomes, yet its widespread clinical adoption faces challenges. By synthesizing current research, this review aims to provide a comprehensive understanding of the CALLY index, highlighting its strengths, limitations, and potential for advancing cancer management in precision medicine.

查看原文本刊更多论文

癌症研究中的CALLY指数：一项综合综述。

本文就CALLY指数在癌症中的应用进行综述，探讨其理论基础、流行病学观点、诊断和预后应用、治疗意义、争议和未来展望。基于C反应蛋白、白蛋白和淋巴细胞水平的CALLY指数已显示出预测癌症预后和指导治疗的潜力。针对不同癌症类型的多项研究表明其与生存结果相关，但其广泛的临床应用面临挑战。通过综合目前的研究，本综述旨在提供对CALLY指数的全面了解，突出其优势，局限性，以及在精准医学中推进癌症管理的潜力。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Oncology Reviews ONCOLOGY-

CiteScore

6.30

自引率

0.00%

发文量

审稿时长

9 weeks

期刊介绍： Oncology Reviews is a quarterly peer-reviewed, international journal that publishes authoritative state-of-the-art reviews on preclinical and clinical aspects of oncology. The journal will provide up-to-date information on the latest achievements in different fields of oncology for both practising clinicians and basic researchers. Oncology Reviews aims at being international in scope and readership, as reflected also by its Editorial Board, gathering the world leading experts in both pre-clinical research and everyday clinical practice. The journal is open for publication of supplements, monothematic issues and for publishing abstracts of scientific meetings; conditions can be obtained from the Editor-in-Chief or the publisher.